Partnership Opportunities
Position Your Company as the go-to Computational Drug Development
Solution Provider
Companies such as GlaxoSmithKline, AstraZeneca, Amgen, AbbVie, Lilly, Novartis, and others are investing heavily in computational tools to benchmark and boost the predictability power in their biologics pipeline. These organizations are seeking innovative partners in AI-driven drug discovery, antibody modelling, biophysical characterization, developability profiling, and high-throughput screening solution providers to accelerate R&D timelines and de-risk decision making.
Join us and build meaningful connections with computational drug development decision makers, hoping to pave new ways to collaborate and accelerate biologics discovery and development across their portfolios.
Collaborate with us to create a bespoke partnership package that aligns with your preferences as solution providers. We are keen to ensure you connect with the individuals you want, in the manner that suits you best. Whether through presentations, one-on-one meetings, booths, or private dinners, take advantage of this opportunity to spotlight your solutions and achieve your 2025 business development objectives.
Having issues downloading the event guide?
Let us know here
Our Bespoke Partnership Package Offers



Demonstrate the benefits of your AI, protein and antibody modelling, biophysical characterisation and developability & high throughput screening solutions to computational drug development decision makers
Exclusive Networking Opportunities – Host private lunches or drinks receptions to connect with key decision-makers, foster meaningful business relationships, and drive your 2025 commercial goals.
Present in-depth talks into your proven solutions and services to build exciting new partnerships with senior computational experts actively seeking solution providers such as yourselves.
Attendee Snapshot










Attendee Breakdown


This meeting is the ultimate forum to showcase the quality of your services and network with Directors of Protein Design, Senior Directors of Biologics, In Silico Leads, AI/ML Research Scientists, Group Leads of Protein Engineering, and more.